Cecilia Kelly

1.1k citations
4 papers · 879 indexed · 1 hit paper · h-index 2
Topics
Advanced Breast Cancer Therapies (1 paper)T-cell and Retrovirus Studies (1 paper)Chronic Disease Management Strategies (1 paper)
Journals
Journal of Clinical OncologyBloodThe Medicine Forum
Partner nations
United StatesSouth Sudan

In The Last Decade

Cecilia Kelly

4 papers receiving 860 citations

Hit Papers

Phase 2 trial of oral vorinostat (suberoylanilide hydroxa...20062026201220192006250500750

Peers

Cecilia Kelly
Comparison fields: 5 of 69
  • Molecular Biology 651
  • Oncology 249
  • Dermatology 205
  • Immunology 159
  • Pathology and Forensic Medicine 154
Replace Larisa J. Geskin with:
Larisa J. Geskin United States
Shanta Chawla United States
Erica Riveiro‐Falkenbach Spain
Ludo M. Evers Netherlands
Kedar Inamdar United States
S. Aidan Quinn United States
Patrick Jedlowski United States
M. Numasaki Japan
Rebeca Manso Spain
Britta Lamottke Germany
Cecilia Kelly relative to Larisa J. Geskin United States Larisa J. Geskin's profile →
Citations per field
00.5×1.5×
Larisa J. Geskin · 1×
Citations per year

Countries citing papers authored by Cecilia Kelly

Since Specialization
Citations

This map shows the geographic impact of Cecilia Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Kelly more than expected).

Fields of papers citing papers by Cecilia Kelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Kelly. The network helps show where Cecilia Kelly may publish in the future.

Co-authorship network of co-authors of Cecilia Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Kelly. A scholar is included among the top collaborators of Cecilia Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Kelly. Cecilia Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)breakdown →
875

About Cecilia Kelly

Cecilia Kelly is a scholar working on Parasitology, Dermatology and Cancer Research, having authored 4 papers that have together received 879 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (1 paper), T-cell and Retrovirus Studies (1 paper) and Chronic Disease Management Strategies (1 paper). The work is most often cited by research in Dermatology (205 citations), Molecular Biology (651 citations) and Oncology (249 citations). Cecilia Kelly has collaborated with scholars based in United States and South Sudan. Frequent co-authors include John F. Reilly, Madeleine Duvic, Stanley R. Frankel, Parul Hazarika, Chunlei Zhang, Xiao Ni, Justin L. Ricker, Judy H. Chiao, Victoria M. Richon and Kelly K. Hunt. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Medicine Forum.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026